Works matching IS 11707690 AND DT 2015 AND VI 33 AND IP 8

Results: 9

Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions.

Published in:

PharmacoEconomics, 2015, v. 33, n. 8, p. 777, doi. 10.1007/s40273-015-0274-y

By:

Frederix, Gerardus;
Haji Ali Afzali, Hossein;
Dasbach, Erik;
Ward, Robyn

Publication type:

Article

The Economic Costs of Type 2 Diabetes: A Global Systematic Review.

Published in:

PharmacoEconomics, 2015, v. 33, n. 8, p. 811, doi. 10.1007/s40273-015-0268-9

By:

Seuring, Till;
Archangelidi, Olga;
Suhrcke, Marc

Publication type:

Article

Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Published in:

PharmacoEconomics, 2015, v. 33, n. 8, p. 833, doi. 10.1007/s40273-015-0272-0

By:

Stevenson, Matt;
Pandor, Abdullah;
Stevens, John;
Rawdin, Andrew;
Rice, Peter;
Thompson, Jez;
Morgan, Marsha

Publication type:

Article

Characterizing Heterogeneity Bias in Cohort-Based Models.

Published in:

PharmacoEconomics, 2015, v. 33, n. 8, p. 857, doi. 10.1007/s40273-015-0273-z

By:

Elbasha, Elamin;
Chhatwal, Jagpreet

Publication type:

Article

Choice of Outcome Measure in an Economic Evaluation: A Potential Role for the Capability Approach.

Published in:

PharmacoEconomics, 2015, v. 33, n. 8, p. 849, doi. 10.1007/s40273-015-0275-x

By:

Lorgelly, Paula

Publication type:

Article

Does it Matter Whether Canada's Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Published in:

PharmacoEconomics, 2015, v. 33, n. 8, p. 879, doi. 10.1007/s40273-015-0278-7

By:

Hoch, Jeffrey;
Beca, Jaclyn;
Sabharwal, Mona;
Livingstone, Scott;
Fields, Anthony

Publication type:

Article

A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE).

Published in:

PharmacoEconomics, 2015, v. 33, n. 8, p. 867, doi. 10.1007/s40273-015-0292-9

By:

Xie, Feng;
Pickard, A.;
Krabbe, Paul;
Revicki, Dennis;
Viney, Rosalie;
Devlin, Nancy;
Feeny, David

Publication type:

Article

The Silence in Hoch et al.'s Commentary about the Rationale for and Objective(s) of Canada's Separate HTA Process for Cancer Drugs: The Importance of Transparency and Accountability when Allocating Taxpayers' Dollars.

Published in:

PharmacoEconomics, 2015, v. 33, n. 8, p. 883, doi. 10.1007/s40273-015-0297-4

By:

McDonald, Heather;
Charles, Cathy;
Elit, Laurie;
Gafni, Amiram

Publication type:

Article

Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.

Published in:

PharmacoEconomics, 2015, v. 33, n. 8, p. 783, doi. 10.1007/s40273-015-0267-x

By:

Diel, Roland;
Lampenius, Niklas;
Nienhaus, Albert

Publication type:

Article